Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BETMAKERS TECHNOLOGY GROUP LTD Capital/Financing Update 2016

Nov 29, 2016

64512_rns_2016-11-29_9562164b-718c-4285-adf4-197348459976.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

TopBetta Holdings Limited ABN: 21 164 521 395 Phone: 1300 886 503 Fax: +61 4962 2553

==> picture [183 x 41] intentionally omitted <==

22 Lambton Road Broadmeadow NSW 2292

30 November 2016

SUCCESSFUL PLACEMENT AND ISSUE OF SHARES

Further to the announcement on 23 November 2016, the Board of TopBetta Holdings Limited (ASX:TBH) (“TopBetta” or “the Company”) is pleased to announce that it has completed the issue and allotment of 15,000,000 fully paid ordinary shares ( Placement ) to raise $3 million (before costs) at 20 cents per share from sophisticated and institutional investors.

The Company also confirms that it has issued the following options to Canaccord Genuity (Australia) Limited ( Canaccord ):

  • 1 million options on the terms and conditions set out in the announcement on 23 November 2016 in consideration for the services provided by Canaccord to TopBetta in connection with the Placement; and

  • 3 million options on the terms and conditions set out in the announcement on 18 August 2016 in consideration for the services provided by Canaccord to TopBetta in the connection with the capital raising announced on 18 August 2016,

  • (together, the Options )

Both the shares issued under the Placement and the Options were issued without a disclosure document in accordance with section 708 of the Corporations Act 2001 (Cth).

The shares issued under the Placement were issued as follows:

  • 3,918,078 shares were issued under the Company’s 15% placement capacity under ASX Listing Rule 7.1; and

  • 11,081,922 shares were issued under the Company’s additional 10% placement capacity under ASX Listing Rule 7.1A.

The Company is extremely pleased with this successful Placement, together with the approval of The Global Tote product by additional racing bodies, as announced on 28 November 2016.

The Board looks forward to updating the market on further progress in the coming weeks.

An Appendix 3B is attached in respect of the Placement.

topbetta.com.au • [email protected] • Postal Address: PO Box 33 Broadmeadow NSW 2292

Information disclosed under ASX Listing Rule 3.10.5A

The following information is provided in accordance with ASX Listing Rules 7.1A.4(b) and 3.10.5A.

1. Details of the dilution to existing holders of ordinary securities caused by the issue:

The Company issued 11,081,922 ordinary shares under Listing Rule 7.1A resulting in the following dilution to existing holders of ordinary securities:

  • Number of fully paid ordinary shares on issue prior to the issue of securities: 110,819,227

  • Add: Number of shares issued as part of the Placement under LR7.1: 3,918,078

  • Total number of fully paid ordinary shares on issue prior to LR7.1A securities issue: 114,737,305

  • Number of shares issued as part of the Placement under LR7.1A: 11,081,922

  • Percentage of voting dilution to existing holders of ordinary securities: 8.81%

2. Where the equity securities are issued for cash consideration, a statement of the reasons why the eligible entity issued the equity securities as a placement under rule 7.1A and not as (or in addition to) a pro rata issue or other type of issue in which existing ordinary security holders would have been eligible to participate:

Given current commercial opportunities and timing considerations, the Company considered the issue of shares to sophisticated and institutional investors to be the most expedient and cost effective method for raising the funds required to strengthen TopBetta’s balance sheet and to fast track the launch of The Global Tote.

3. Details of any underwriting arrangements including any fees payable to the underwriter:

No underwriting arrangements were entered into in respect of the shares issued under the Placement.

4. Any fees or costs incurred in connection with the issue:

1 million options were issued to Canaccord (on the terms and conditions set out in the announcement on 23 November 2016) in consideration for its services as sole lead manager and bookrunner for the Placement. No other fees have been incurred in connection with the issue.

Separately, below is a cleansing statement required to remove secondary trading restrictions.

2

Notice given under Section 708A(5) of the Corporations Act

The Company hereby notifies ASX that:

  1. today, being 30 November 2016, the Company completed the issue and allotment of 15,000,000 fully paid ordinary shares;

  2. the Company issued the securities without disclosure to investors under Part 6D.2 of the Act; 3. the Company provides this notice under section 708A(5)(e) of the Corporations Act 2001 (Cth);

  3. as at the date of this notice the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company;

  4. as at the date of this notice, the Company has complied with section 674 of the Act;

  5. for the purposes of section 708A(7) and (8) of the Corporations Act, the Company wishes to disclose that The Global Tote Limited, the Company's wholly owned subsidiary, is in advanced negotiations with a major corporate bookmaker in respect of The Global Tote product. Negotiations are not complete and terms have not yet been agreed. A detailed announcement will be made if and when final terms are agreed and otherwise in compliance with the Company’s continuous disclosure obligations.

  6. other than as set out above, as at the date of this notice, there is no information:

  7. a. that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules;

  8. b. that investors and their professional advisors would reasonably require for the purpose of making an informed assessment of:

    • i. the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

    • ii. the rights and liabilities attaching to the fully paid ordinary shares.

For further information, please contact:

Charly Duffy Jane Morgan Company Secretary Investor & Media Relations [email protected] [email protected] + 61 (0) 409 083 780 + 61 (0) 405 555 618

3

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

TopBetta Holdings Limited

ABN

21 164 521 395

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or
to be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
1) Ordinary Shares
2) Unlisted Options
1) 15,000,000 Ordinary Shares
2) 4,000,000 Unlisted Options
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

3
Principal
terms
of
the
+securities
(e.g.
if
options,
exercise price and expiry date;
if partly paid+securities, the
amount outstanding and due
dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for
conversion)
1) The Ordinary Shares will be issued at
$0.20 per share.
2) 1,000,000 of the Unlisted Options
(November Placement Options) will
be exercisable at $0.30 within 3 years
from the date of issue, which will vest
on the earlier of:
a) 30 November 2017; or
b) the Company’s volume weighted
share price trading above $0.50 for
a period of at least one month.
3) 3,000,00
of
the
Unlisted
Options
(August Placement Options) will be
exercisable at $0.25 within 3 years from
the date of issue, vesting as follows:
a) 1,500,000 of Unlisted Options will
vest on 23 August 2017; and
b) 1,500,000 Unlisted Options will
vest upon the earlier of:
i)
23 August 2017; or
ii) the
Company’s
volume
weighted share price trading
above $0.50 for a period of at
least one month.
4
Do the+securities rank equally
in all respects from the+issue
date with an existing+class of
quoted+securities?
If the additional+securities do
not rank equally, please state:
•the date from which they do
•the extent to which they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
•the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
1) Yes. The Ordinary Shares will rank
equally with all other Ordinary Shares in
the Company.
2) No, the August Placement Options and
the November Placement Options will
each form a new class of securities. The
shares issued on exercise of the
Unlisted Options will rank equally in all
respects with existing Ordinary Shares
issued.
1) $0.20 per Ordinary Share
2) Nil
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity
that
has
obtained
security
holder
approval
under
rule
7.1A?
If Yes, complete sections 6b –
6h_in relation to the+securities_
the subject of this Appendix 3B,
and comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number of+securities issued
without security holder approval
under rule 7.1
6d
Number of+securities issued
with security holder approval
under rule 7.1A
6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific
security
holder
approval
(specify
date
of
meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least
75% of 15 day VWAP as
calculated under rule 7.1A.3?
Include the+issue date and
both values. Include the source
of the VWAP calculation.
1) The Ordinary Shares have been issued to
raise $3 million to strengthen the Company’s
working capital reserves and fast track
launch of The Global Tote.
2) The Unlisted Options have been issued in
consideration of brokerage services provided
to the Company in respect of the Placements
completed on 23 August 2016 and 30
November 2016.
Yes
22 November 2016
1,000,000 Unlisted Options
3,918,078 Ordinary Shares
11,081,922 Ordinary Shares
3,000,000 Unlisted Options approved under
ASX Listing Rule 7.4 on 22 November 2016
N/A

Yes, the Shares were issued at $0.20 per share
on 30 November 2016.
75% of the 15 day VWAP calculated under
Listing Rule 7.1A.3 was $0.14385.
VWAP source – Yahoo Finance
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which valuation of consideration
was released to ASX Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1
and rule 7.1A – complete
Annexure 1 and release to ASX
Market Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for
a pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)
N/A
7.1: 11,704,806
7.1A: 0
30 November 2016.
Number +Class
112,254,776 Fully
paid
ordinary
shares
  • See chapter 19 for defined terms.

Appendix 3B Page 4

30/06/2016

Appendix 3B New issue announcement

9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
13,564,451
10,000,000
16,667,000
2,000,000
1,000,000
3,000,000
Fully
paid
ordinary
shares
(subject
to
various
escrow
periods)
Unlisted
Options
(exercisable at $0.20;
expiring
12/11/18;
escrowed to 12/11/17)
Unlisted
Options
(exercisable at $0.25;
expiring
12/11/20;
escrowed to 12/11/17;
subject
to
various
performance hurdles)
Unlisted
Options
(exercisable at $0.25;
expiring
21/3/19;
subject
to
various
performance hurdles)
Unlisted
Options
(exercisable at $0.30;
expiring
30/11/19;
subject
to
vesting
conditions)
Unlisted
Options
(exercisable at $0.25;
expiring
30/11/19;
subject
to
vesting
conditions)
N/A

Part 2 - Pro rata issue

  • 11 Is security holder approval N/A required?

  • 12 Is the issue renounceable or N/A non-renounceable?

  • 13 Ratio in which the[+] securities will N/A be offered

  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

14
+Class of+securities to which
the offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements
in relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the
issue
23
Fee or commission payable to
the broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date
entitlement
and
acceptance
form
and
offer
documents
will
be
sent
to
persons entitled
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 6

30/06/2016

Appendix 3B New issue announcement

27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell
their entitlements_in full_through
a broker?
31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

35[If the ][+][securities are ][+][equity securities, the names of the 20 largest holders of ] the additional[+] securities, and the number and percentage of additional +securities held by those holders

36[If the ] +securities setting out the number of holders in the categories[+][securities are ][+][equity securities, a distribution schedule of the additional ] 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37[A copy of any trust deed for the additional ][+][securities ]

Entities that have ticked box 34(b)

38 Number of[+] securities for which +quotation is sought 39 +Class of +securities for which quotation is sought

  • 40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class

  • See chapter 19 for defined terms.

Appendix 3B Page 8

30/06/2016

Appendix 3B New issue announcement

42 Number and +class of all +securities quoted on ASX ( including the +securities in clause 38)

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

    • Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 30 / 11 / 2016 (Company Secretary) Print name: Charly Duffy

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

== == == == ==

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1 Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insertnumber of fully paid+ordinary
securities on issue 12 months before the
+issue date or date of agreement to issue
96,364,546
Addthe following:

Number of fully paid+ordinary securities
issued in that 12 month period under an
exception in rule 7.2

Number of fully paid+ordinary securities
issued in that 12 month period with
shareholder approval

Number of partly paid+ordinary
securities that became fully paid in that
12 month period
Note:

Include only ordinary securities here –
other classes of equity securities cannot
be added

Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed

It may be useful to set out issues of
securities on different dates as separate
line items
14,454,681 Ordinary Shares issued on 23
August 2016 approved at the meeting held
on 22 November 2016.
Subtractthe number of fully paid+ordinary
securities cancelled during that 12 month
period
0
“A” 110,819,227
  • See chapter 19 for defined terms.

Appendix 3B Page 10

30/06/2016

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 16,622,884
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:

Under an exception in rule 7.2

Under rule 7.1A

With security holder approval under rule
7.1 or rule 7.4
Note:

This applies to equity securities, unless
specifically excluded – not just ordinary
securities

Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed

It may be useful to set out issues of
securities on different dates as separate
line items
1,000,000 Unlisted Options issued on 30
November 2016
3,918,078 Ordinary Shares issued on 30
November 2016
“C” 4,918,078
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
16,622,884
Subtract“C”
Note: number must be same as shown in
Step 3
4,918,078
Total[“A” x 0.15] – “C” 11,704,806
  • See chapter 19 for defined terms.

Appendix 3B Page 11

09/05/2013

Appendix 3B New issue announcement

Part 2

Part 2 Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
110,819,227
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply“A” by 0.10 11,081,922
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:

This applies to equity securities – not
just ordinary securities

Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed

Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained

It may be useful to set out issues of
securities on different dates as separate
line items
11,081,922 Ordinary Shares
“E” 11,081,922
  • See chapter 19 for defined terms.

Appendix 3B Page 12

30/06/2016

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
11,081,922
Subtract“E”
Note: number must be same as shown in
Step 3
11,081,922
Total[“A” x 0.10] – “E” 0
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 13

09/05/2013